CORRECTSEQUENCE THERAPEUTICS Trademark
Trademark Overview
On Monday, January 17, 2022, a trademark application was filed for CORRECTSEQUENCE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CORRECTSEQUENCE THERAPEUTICS trademark a serial number of 97222611. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, July 19, 2024. This trademark is owned by CorrectSequence Therapeutics Co., Ltd. The CORRECTSEQUENCE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for use in the treatment of diseases caused by point mutations; Drugs being pharmaceutical preparations for medical purposes for the treatment of diseases caused by point mutations; Stimulants for the central nervous system; Vaccines; Preparations of microorganisms for medical or veterinary use; Cultures of microorganisms for medical and veterinary use; Biological tissue cultures for medical purposes; Diagnostic biomarker reagents for medical purposes; Implants comprising living tissues for transplants; Reagents for medical genetic testing; Stem cells for medical purposes; Pharmaceutical preparations acting on the central nervous system
Biological research and analysis; Scientific research in the nature of conducting research and clinical trials for others; Genetic testing for scientific research purposes; Biomedical Research Services; Medical Research Services; Development of pharmaceutical preparations and medicines; Drug Research Services being pharmaceutical research; Structural and functional analysis of genomes
General Information
| Serial Number | 97222611 |
| Word Mark | CORRECTSEQUENCE THERAPEUTICS |
| Filing Date | Monday, January 17, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Friday, July 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 30, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for use in the treatment of diseases caused by point mutations; Drugs being pharmaceutical preparations for medical purposes for the treatment of diseases caused by point mutations; Stimulants for the central nervous system; Vaccines; Preparations of microorganisms for medical or veterinary use; Cultures of microorganisms for medical and veterinary use; Biological tissue cultures for medical purposes; Diagnostic biomarker reagents for medical purposes; Implants comprising living tissues for transplants; Reagents for medical genetic testing; Stem cells for medical purposes; Pharmaceutical preparations acting on the central nervous system |
| Pseudo Mark | CORRECT SEQUENCE THERAPEUTICS |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Biological research and analysis; Scientific research in the nature of conducting research and clinical trials for others; Genetic testing for scientific research purposes; Biomedical Research Services; Medical Research Services; Development of pharmaceutical preparations and medicines; Drug Research Services being pharmaceutical research; Structural and functional analysis of genomes |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 21, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 21, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | CorrectSequence Therapeutics Co., Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Shanghai 200120
CN |
| Party Name | CorrectSequence Therapeutics Co., Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Shanghai 200120
CN |
Trademark Events
| Event Date | Event Description |
| Friday, January 21, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 20, 2022 | NEW APPLICATION ENTERED |
| Tuesday, October 25, 2022 | ASSIGNED TO EXAMINER |
| Friday, October 28, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, October 28, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, October 28, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, April 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 24, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 10, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 30, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 25, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, January 25, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 25, 2024 | SOU EXTENSION 1 FILED |
| Thursday, January 25, 2024 | SOU EXTENSION 1 GRANTED |
| Saturday, January 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, July 19, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 19, 2024 | SOU EXTENSION 2 FILED |
| Friday, July 19, 2024 | SOU EXTENSION 2 GRANTED |
| Wednesday, July 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 30, 2023 | PUBLISHED FOR OPPOSITION |
